Wei Li Lin
Directeur/Membre du Conseil chez HANDA PHARMACEUTICALS, INC.
Profil
Wei Li Lin is currently the Chairman of Chuan Fa Biotechnology Co. Ltd., Director-Supervisory Board of Microbio (Shanghai) Co., Ltd., and an Independent Director at Handa Pharmaceuticals, Inc. He previously served as Chairman, President & Spokesman at Fountain Biopharma, Inc. and as a Director at OBI Pharma, Inc. Dr. Lin holds a doctorate degree from Kansas State University.
Postes actifs de Wei Li Lin
Sociétés | Poste | Début |
---|---|---|
HANDA PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 28/09/2017 |
Microbio (Shanghai) Co., Ltd. | Directeur/Membre du Conseil | - |
Chuan Fa Biotechnology Co. Ltd. | Président | - |
Anciens postes connus de Wei Li Lin
Sociétés | Poste | Fin |
---|---|---|
OBI PHARMA, INC. | Directeur/Membre du Conseil | 20/12/2012 |
FOUNTAIN BIOPHARMA INC | Président | - |
Formation de Wei Li Lin
Kansas State University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
OBI PHARMA, INC. | Health Technology |
HANDA PHARMACEUTICALS, INC. | Health Technology |
Entreprise privées | 3 |
---|---|
Fountain Biopharma, Inc.
Fountain Biopharma, Inc. Pharmaceuticals: OtherHealth Technology Fountain Biopharma, Inc. engages in the research, development and sales of antibody drugs. Its products include anti-allergic monoclonal antibody drugs, monoclonal antibody drugs, immune checkpoint aptamer drugs, anti-lag-3 immunological checkpoint aptamer drugs and anti-tumor stem cell labeled antibody drugs. The company was founded on November 25, 2010 and is headquartered in Taipei, Taiwan. | Health Technology |
Microbio (Shanghai) Co., Ltd. | |
Chuan Fa Biotechnology Co. Ltd. |